Completion Of Retaining Piles For Ghora Howk And Progress On Multiple Key Projects Of CBD Punjab Discussed.

Lahore (Muhammad Yasir)

Punjab Central Business District Development Authority also known as Central Business District Punjab (CBD Punjab), is making significant strides in its ongoing projects under the dynamic leadership of CEO Imran Amin. A progress review meeting was chaired by CEO CBD Punjab Imran Amin to closely examine the progress of the Ghora Chowk Flyover, Executive Director Technical CBD Punjab, Riaz Hussain, provided a comprehensive briefing on the ongoing progress of the project The meeting was attended by the Director Business Development CBD Punjab, Ali Waqar Shah, Director Marketing CBD Punjab, Waseem Siddiq, Director Architecture CBD Punjab, Sameer Aftab, Director Construction CBD Punjab, .Asif Babar, along with officials from Nespak and NLC. CEO CBD Punjab, Imran Amin, stressed the importance of adhering to the vision and directives of Chief Minister Punjab Mohsin Raza Naqvi to ensure the timely completion of the project. While addressing the meeting Imran Amin said, “We are fully committed to completing the project in the stipulated time. This project is pivotal for the prosperity of the region, and will improve overall mobility in the area.” During the meeting, the technical team reported that all 33 retaining piles for the Ghora Chowk Flyover are completed and the boundary wall is also near completion. They also highlighted the round-the-clock work at the Ghora Chowk site, with three rig machines in operation. Additionally, the pile load test for the Ghora Chowk Flyover is also completed.

CEO CBD Punjab Imran Amin was also given a brief update about other projects of the authority including the upgradation of Walton Road, the construction of a road connecting CBD Punjab Boulevard, CBD Quaid District, and Walton Road, the construction of an overhead crossing bridge at Walton railway crossing, the infrastructure development of CBD Punjab and the construction of the parking plaza at CBD Punjab project site.

The Crucial Role of Clinical Trials in Medical Progress

Karachi (Muhammad Yasir)

Conducting clinical trials is always challenging however these challenges are magnified in low and middle-income countries, said Prof Dr. Faisal Mahmood, Section Head of infectious diseases at Aga Khan University. He shared the many challenges that are particular to LMICs, especially in the context of Pakistan, while speaking at a Media Roundtable on “COVID-19 and the importance of clinical trials.” Clinical trials have long stood as the cornerstone of medical progress, playing an indispensable role in the development and validation of new treatments, therapies, and medical interventions.

Speaking on Ethical and Regulatory aspects of clinical trials Dr. Sadia Asim, Director Clinical trial site and CRO at Dow University of Health Sciences (DUHS) said, that in Pakistan the trial is controlled through DRAP regulations (Laws) and it’s conducted based on prescribed ethical guidelines, to ensure the rights of human beings during the execution of clinical trials. Clinical trials have been an essential part of improving healthcare for humans. This research is done in an organised, systematic and ethical way for almost all the drugs we benefit from today, stated Dr. Saima Saeed, a Consultant pulmonologist and Director, Lung Health at Indus Hospital and Health Network. An example is antibiotics for infections. For example, we have learnt about the best treatments for TB using clinical trials and this and other infections were previously lethal. Similarly, trials allowed us to understand how well different Covid treatments work for those people in hospital and there are ongoing trials about how to reduce symptoms in mild and moderate symptoms.

Clinical trials involve the careful monitoring and testing of these interventions in carefully selected groups of participants, following strict protocols designed to ensure the highest standards of safety and ethical practice. Sharing the various stages of a clinical trial, Dr. Muneeba A. Sayyed, Assistant Professor/Head of Department of Infectious Diseases at Sindh Infectious Diseases Hospital & Research Centre/ DUHS said that a Clinical Trial is a type of research that studies new tests, treatment and procedures and evaluates their safety and effectiveness on human health outcomes. Before approval, the drug or procedure has to pass through different phases of clinical trials. Phase I assesses the safety and dosage of drugs in a small group of healthy volunteers or patients. Phase II assesses the effectiveness in a larger group while in phase III it is compared with standard treatment in a large population of different regions and countries. Phase IV monitors long-term effects after the drug or procedure has been approved and marketed.

All speakers were of the opinion that Clinical trials not only target life-threatening conditions but also seek to enhance the quality of life for patients living with chronic illnesses. They also informed the audience that AKUH, DUHS OJHA Campus, Indus Hospital & Healthcare Network, and the SIDH are facilitating the general public by offering free COVID-19 Tests to those who are showing relative symptoms, so that there is early detection of the virus as various different variants are still prevalent in Pakistan. As the world faces an ever-evolving healthcare landscape, clinical trials remain the bedrock of medical progress. Their impact on patient well-being, scientific knowledge, and the global healthcare system cannot be overstated. Through ongoing support and participation in clinical trials, we collectively advance towards a healthier, more innovative future.